These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71. Vascular and renal telomere shortening in mice exposed to chronic intermittent hypoxia. Badran M; Abuyassin B; Ayas N; Sin DD; Laher I Can J Physiol Pharmacol; 2021 Oct; 99(10):1112-1113. PubMed ID: 33951396 [TBL] [Abstract][Full Text] [Related]
72. Characteristics and mortality of Mexican patients with COVID-19 and mechanical ventilation. Álvarez-Maldonado P; Hernández-Ríos G; Ambríz-Mondragón JC; Gordillo-Mena JA; Morales-Serrano DF; Reding-Bernal A; Hernández-Solis A Gac Med Mex; 2021; 157(1):97-101. PubMed ID: 34125809 [TBL] [Abstract][Full Text] [Related]
73. Risk Factors of Infection, Hospitalization and Death from SARS-CoV-2: A Population-Based Cohort Study. Castilla J; Guevara M; Miqueleiz A; Baigorria F; Ibero-Esparza C; Navascués A; Trobajo-Sanmartín C; Martínez-Baz I; Casado I; Burgui C; Ezpeleta C; The Working Group For The Study Of Covid-In Navarra J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34199198 [TBL] [Abstract][Full Text] [Related]
74. COVID-19 vaccines are effective in people with obesity: A position statement from The Obesity Society. Butsch WS; Hajduk A; Cardel MI; Donahoo WT; Kyle TK; Stanford FC; Zeltser LM; Kotz CM; Jastreboff AM Obesity (Silver Spring); 2021 Oct; 29(10):1575-1579. PubMed ID: 34212511 [TBL] [Abstract][Full Text] [Related]
75. Is Obesity a Potential Risk factor for Poor Prognosis of COVID-19? Agca M; Tuncay E; Yıldırım E; Yıldız R; Sevim T; Ernam D; Yılmaz NO; Teke NH; Yavuz S; Karakurt Z; ; Ozmen I Infect Chemother; 2021 Jun; 53(2):319-331. PubMed ID: 34216125 [TBL] [Abstract][Full Text] [Related]
76. COVID-19 and obesity: fighting two pandemics with intermittent fasting. Ealey KN; Phillips J; Sung HK Trends Endocrinol Metab; 2021 Sep; 32(9):706-720. PubMed ID: 34275726 [TBL] [Abstract][Full Text] [Related]
77. COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention. Sharma JR; Yadav UCS Obes Res Clin Pract; 2021; 15(2):163-171. PubMed ID: 33509701 [TBL] [Abstract][Full Text] [Related]
78. Obesity, a major risk factor for immunity and severe outcomes of COVID-19. Amin MT; Fatema K; Arefin S; Hussain F; Bhowmik DR; Hossain MS Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34350941 [TBL] [Abstract][Full Text] [Related]
79. Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health Care. Sattar N; Valabhji J Curr Obes Rep; 2021 Sep; 10(3):282-289. PubMed ID: 34374955 [TBL] [Abstract][Full Text] [Related]
80. Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK Biobank. Yates T; Razieh C; Zaccardi F; Rowlands AV; Seidu S; Davies MJ; Khunti K Int J Obes (Lond); 2021 May; 45(5):1155-1159. PubMed ID: 33637952 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]